Learn More
IFPRI was established in 1975 to identify and analyze national and international strategies and policies for meeting the food needs of the developing world on a sustainable basis, with particular emphasis on low-income countries and poor people; to make the results of its research available to all those in a position to use them; and to help strengthen(More)
  • Hans Lofgren
  • 2004
Consumer and patient advocacy groups (PAGs) are important participants in the politics of pharmaceuticals. Yet very little is known about the precise nature and extent of their influence. It is argued in this article that PAGs fulfil a mixed role within the health system at national and transnational levels, and that they are at times fully incorporated(More)
This chapter presents a technique for evaluating the impact of economic " shocks " — policy changes and exogenous events — on poverty and inequality, based on a computable general equilibrium (CGE) model with representative households (RHs) that are linked to a household module. Any analysis of the impact of major economic shocks (for example a significant(More)
TMD Discussion Papers contain preliminary material and research results, and are circulated prior to a full peer review in order to stimulate discussion and critical comment. It is expected that most Discussion Papers will eventually be published in some other form, and that their content may also be revised. This paper was written under the IFPRI project "(More)
TMD Discussion Papers contain preliminary material and research results, and are circulated prior to a full peer review in order to stimulate discussion and critical comment. It is expected that most Discussion Papers will eventually be published in some other form, and that their content may also be revised. ABSTRACT In MENA, household food insecurity,(More)
India has built a large pharmaceutical industry through an array of measures in support of domestic firms. The absence of product patents enabled Indian companies to become world leading producers of generic versions of patented drugs. Low costs and a strong engineering tradition continue to sustain competitive strength. The implementation of the World(More)